Results 251 to 260 of about 61,706 (295)
Some of the next articles are maybe not open access.
Non-proliferative diabetic retinopathy symptoms detection and classification using neural network
Journal of Medical Engineering & Technology, 2017Diabetic retinopathy (DR) causes blindness in the working age for people with diabetes in most countries. The increasing number of people with diabetes worldwide suggests that DR will continue to be major contributors to vision loss. Early detection of retinopathy progress in individuals with diabetes is critical for preventing visual loss.
M. Al-Jarrah, Hadeel Shatnawi
semanticscholar +3 more sources
Non-proliferative diabetic retinopathy detection using mathematical morphology
2018 IEEE 4th Middle East Conference on Biomedical Engineering (MECBME), 2018Diabetes might be the cause of lots of visual troubles (when it is poorly controlled); it induces the thickening and hardening of the retina's blood vessels and prevents the accomplishment of its function suitably. Among the complications of diabetes on the eye, there is the diabetic retinopathy, which is considered as a major cause of blindness in the
Bouacheria Mohamed +4 more
openaire +1 more source
Retinal Vessel Segmentation of Non-Proliferative Diabetic Retinopathy
International Journal of Applied Evolutionary Computation, 2019Diabetic retinopathy is a disease in diabetic patients that affects the eye. It happens due to damage in the blood vessels of the light-sensitive tissues at the retina. In non-proliferative diabetic retinopathy, tiny changes occur in the blood vessels of the eye. Non-proliferative diabetic retinopathy can trigger macular edema or macular ischemia.
Santosh S. Chowhan +2 more
openaire +1 more source
Characterisation of human non-proliferative diabetic retinopathy using the fractal analysis.
To investigate and quantify changes in the branching patterns of the retina vascular network in diabetes using the fractal analysis method.This was a clinic-based prospective study of 172 participants managed at the Ophthalmological Clinic of Cluj-Napoca, Romania, between January 2012 and December 2013.
Ș. Țălu, D. Călugăru, C. Lupascu
semanticscholar +3 more sources
European Journal of Ophthalmology, 2020
Purpose: To investigate aqueous humor (AH) and serum levels of brain-derived neurotrophic factor (BDNF) in non-proliferative diabetic retinopathy (NPDR) patients with diabetic macular edema (DME). Methods: The prospective study consists of 20 patients with DME NPDR, 20 patients with no-DME NPDR, and 20 healthy control subjects.
Yong Hyun Jun, Seong Taeck Kim
openaire +2 more sources
Purpose: To investigate aqueous humor (AH) and serum levels of brain-derived neurotrophic factor (BDNF) in non-proliferative diabetic retinopathy (NPDR) patients with diabetic macular edema (DME). Methods: The prospective study consists of 20 patients with DME NPDR, 20 patients with no-DME NPDR, and 20 healthy control subjects.
Yong Hyun Jun, Seong Taeck Kim
openaire +2 more sources
Non proliferative diabetic retinopathy and macular edema
Insight - the Journal of the American Society of Ophthalmic Registered Nurses, 1999As previously noted, although visual loss usually does not fall below 20/200 in the presence of ME, it may nevertheless be a significant disability. Additional interventions may include referral to low vision clinics, home health agencies, visual loss support groups, and local or regional blindness agencies to aid the patient's occupational ...
openaire +2 more sources
Multimedia tools and applications, 2023
P. Saranya, K. M. Umamaheswari
semanticscholar +1 more source
P. Saranya, K. M. Umamaheswari
semanticscholar +1 more source
Graefe's Archive for Clinical and Experimental Ophthalmology, 2022
Elias Khalili pour +13 more
semanticscholar +1 more source
Elias Khalili pour +13 more
semanticscholar +1 more source
Is docosahexaenoic acid supplementation effective in non‐proliferative diabetic retinopathy?
Acta Ophthalmologica, 2022AbstractWe evaluated the effect of 2‐year supplementation with a highly concentrated docosahexaenoic acid (DHA) product with antioxidant activity on nonproliferative diabetic retinopathy (NPDR). A prospective, randomized, double‐blind, placebo‐controlled study was performed. A total of 170 patients with diabetes were randomly assigned to the DHA group (
openaire +1 more source

